Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

154
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
154
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

151
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
151
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions01:09

Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions

223
Renal clearance plays a pivotal role in drug elimination from the body and can be influenced by drug distribution and interactions. Understanding these factors is crucial in pharmacology as they impact the effectiveness and duration of drug therapy.
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
223
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

267
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
267
Renal Drug Clearance: Overview01:06

Renal Drug Clearance: Overview

321
Renal clearance is a crucial parameter in pharmacokinetics that quantifies the rate at which the kidneys excrete a drug. It represents a constant fraction of the central volume of distribution containing the drug that the kidney eliminates per unit of time.
Renal clearance can be calculated using different methods. One approach is to divide the urinary drug excretion rate by the plasma drug concentration. This method directly measures renal clearance, indicating the kidneys' efficiency in...
321
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Evaluating the implementation of Electronic Palliative Care Co-ordination Systems (EPaCCS) and optimising future service provision for palliative and end-of-life care: a synopsis of the Optimal Care mixed-method study.

Health and social care delivery research·2026
Same author

Transitions of care following acute kidney injury: a systems-based analysis.

BMC nephrology·2026
Same author

Comparing paper Letters in addition to Emailed Audit and feedback in Refining Asthma treatment to Improve clinical and environmental Results in primary care through a cluster randomised controlled trial: the CLEAR AIR study.

BMJ open respiratory research·2026
Same author

Acceptability, appropriateness and costs of a tailored implementation strategy for the national falls prevention recommendations in Norwegian municipalities-a process evaluation of the FALLPREVENT trial.

Age and ageing·2026
Same author

Defining Patient and Public Involvement and Engagement Tasks in Health Data Research: A Consensus Study.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Experience-based co-design informed development of a toolbox to help optimise primary care support during transition from children's hospice care: HOPSCOTCH study protocol.

BMJ open·2025

相关实验视频

Updated: Sep 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

通过实践反来优化肌素清除,降低功能和处方安全:混合方法研究

Su I Wood1, Robbie Foy1, Paul Carder2

  • 1Division of Primary Care, Palliative Care and Public Health, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9LN, United Kingdom.

Family practice
|September 5, 2025
PubMed
概括

在老年人中,性能反改善了肌素清除率 (CrCl) 的计算和编码,但需要进一步的系统支持来减少功能下降的药物错误.

关键词:
可行性研究一般的做法纵向研究处方时间质量研究质量和安全性

更多相关视频

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.5K

相关实验视频

Last Updated: Sep 9, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833
Direct Drug Delivery to Kidney via the Renal Artery
11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.5K

科学领域:

  • 老年医学
  • 临床药房
  • 医疗服务研究

背景情况:

  • 随着年龄的增长,功能自然下降,因药物水平较高而增加药物不良事件的风险.
  • 在肌素清除率 (CrCl) 降低的老年患者中,不适当的处方是常见的.

研究的目的:

  • 评估性能反干预措施的可行性和可接受性.
  • 增强CrCl计算和编码实践.
  • 减少可能不合适的处方在老年人.

主要方法:

  • 一项混合方法研究,涉及基于证据的CrCl编码和处方反在七个英国的一般实践中.
  • 在三个时间点收集数据,进行干预前/后评估.
  • 机构民族学包括观察和与初级保健医生的半结构面试.

主要成果:

  • 75岁及以上患者的平均CrCl编码从46%增加到50. 4%.
  • 观察到与CrCl相关的不适当处方患者数量有所减少.
  • 临床医生发现反具有吸引力和灵活性,尽管在CrCl计算和药物召回方面存在挑战.

结论:

  • 绩效反可以促进对功能下降的处方,但需要额外的支持.
  • 通过更好的决策支持来提高患者的安全性,系统化CrCl计算和编码至关重要.
  • 大规模的有效性评估被认为是可行的和可接受的.